Category 1: The “Risk Promoters” Centered on EPHB4. Our research found that eight NSAIDs, represented by aspirin and celecoxib, share a common target, the EPHB4 gene, which has a robust causal association with an increased risk of endometriosis (EMS). Here, EPHB4 is linked to endometriosis.